iCAD will highlight its suite of advanced cancer detection and workflow tools, including PowerLook Mammo Detection, PowerLook Density Assessment, PowerLook Tomo Detection and VeraLook CTC colon polyp detection technology at its booth #4129 in the South Hall at RSNA 2016.
iCAD's PowerLook Tomo Detection, designed to improve digital breast tomosynthesis reading workflow, has CE Mark and is installed at multiple facilities in Europe and is approved for sale in Canada. It is currently pending FDA approval.
Also during the meeting, research will be presented at two separate sessions that focus on utilizing the PowerLook Tomo Detection workflow solution.
iCAD tomosynthesis solutions are investigational devices in the US and limited by US Federal Law to investigational use.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes.
iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers.
iCAD's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue.
The Xoft System is FDA cleared, CE marked, and licensed in Canada for the treatment of cancer anywhere in the body, including treatment of early-stage breast cancer, gynecological cancers and non-melanoma skin cancer.